Interleukin-1 and the inflammasome as therapeutic targets in cardiovascular disease

A Abbate, S Toldo, C Marchetti, J Kron… - Circulation …, 2020 - Am Heart Assoc
The intracellular sensing protein termed NLRP3 (for NACHT, LRR, and PYD domains-
containing protein 3) forms a macromolecular structure called the NLRP3 inflammasome …

[HTML][HTML] Interleukin 1α: a comprehensive review on the role of IL-1α in the pathogenesis and treatment of autoimmune and inflammatory diseases

G Cavalli, S Colafrancesco, G Emmi, M Imazio… - Autoimmunity …, 2021 - Elsevier
Abstract The interleukin (IL)-1 family member IL-1α is a ubiquitous and pivotal pro-
inflammatory cytokine. The IL-1α precursor is constitutively present in nearly all cell types in …

Acute pericarditis: update

E Lazarou, P Tsioufis, C Vlachopoulos… - Current Cardiology …, 2022 - Springer
Abstract Purpose of Review Since 2015, when ESC guidelines for the diagnosis and
management of pericardial diseases were published, ongoing research has enhanced the …

Anti-inflammatory therapies for pericardial diseases in the COVID-19 pandemic: safety and potentiality

M Imazio, A Brucato, G Lazaros, A Andreis… - Journal of …, 2020 - journals.lww.com
The COVID-19 pandemic is challenging our cardiovascular care of patients with heart
diseases. In the setting of pericardial diseases, there are two possible different scenarios to …

[HTML][HTML] The IL-1 cytokine family as custodians of barrier immunity

L Matarazzo, YEH Santana, PT Walsh, PG Fallon - Cytokine, 2022 - Elsevier
Abstract The interleukin-1 (IL-1) family of cytokines and receptors are implicated in the
functioning of innate and adaptive immunity and the genesis of inflammation. They are …

Immunomodulating therapies in acute myocarditis and recurrent/acute pericarditis

E Ammirati, E Bizzi, G Veronese, M Groh… - Frontiers in …, 2022 - frontiersin.org
The field of inflammatory disease of the heart or “cardio-immunology” is rapidly evolving due
to the wider use of non-invasive diagnostic tools able to detect and monitor myocardial …

The impact of cytokines in coronary atherosclerotic plaque: current therapeutic approaches

P Tsioufis, P Theofilis, K Tsioufis… - International Journal of …, 2022 - mdpi.com
Coronary atherosclerosis is a chronic pathological process that involves inflammation
together with endothelial dysfunction and lipoprotein dysregulation. Experimental studies …

Anti-interleukin-1 agents for pericarditis: a primer for cardiologists

M Imazio, G Lazaros, M Gattorno… - European Heart …, 2022 - academic.oup.com
Abstract Anti-interleukin (IL)-1 agents have been developed for the treatment of
autoinflammatory and rheumatic conditions, where overproduction of IL-1 is an important …

Treatment of idiopathic recurrent pericarditis with goflikicept: phase II/III study results

VY Myachikova, AL Maslyanskiy, OM Moiseeva… - Journal of the American …, 2023 - jacc.org
Background Idiopathic recurrent pericarditis (IRP) is a rare autoinflammatory disease.
Interleukin (IL)-1α and IL-1β are the pivotal cytokines in the pathophysiology of acute …

Recent advances in pericarditis

E Bizzi, C Picchi, G Mastrangelo, M Imazio… - European Journal of …, 2022 - Elsevier
Pericardial diseases are an heterogeneous group of entities, ranging from acute pericarditis
to asymptomatic pericardial effusions. New advances in understanding the processes …